Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists

Johannes F. E. Mann, Marcel H. A. Muskiet

Research output: Contribution to journal › Comment/Letter to the editor › Academic

14 Citations (Scopus)

Access to Document

@article{0585e1516e09473fbfbd6455cf2be793,

title = "Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists",

author = "Mann, {Johannes F. E.} and Muskiet, {Marcel H. A.}",

year = "2021",

month = feb,

day = "1",

doi = "https://doi.org/10.1016/j.kint.2020.08.036",

language = "English",

volume = "99",

pages = "314--318",

journal = "Kidney International",

issn = "0085-2538",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Incretin-based drugs and the kidney in type 2 diabetes: choosing between DPP-4 inhibitors and GLP-1 receptor agonists

AU - Mann, Johannes F. E.

AU - Muskiet, Marcel H. A.

PY - 2021/2/1

Y1 - 2021/2/1

UR - http://www.scopus.com/inward/record.url?scp=85099804138&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.kint.2020.08.036

DO - https://doi.org/10.1016/j.kint.2020.08.036

M3 - Comment/Letter to the editor

C2 - 33509353

SN - 0085-2538

VL - 99

SP - 314

EP - 318

JO - Kidney International

JF - Kidney International

IS - 2

ER -